Loading...

Targeting the ubiquitin-proteasome system for cancer treatment: discovering novel inhibitors from nature and drug repurposing

In the past fifteen years, the proteasome has been validated as an anticancer drug target and 20S proteasome inhibitors (such as bortezomib and carfilzomib) have been approved by the FDA for the treatment of multiple myeloma and some other liquid tumors. However, there are shortcomings of clinical p...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Cancer Metastasis Rev
Main Authors: Soave, Claire L., Guerin, Tracey, Liu, Jinbao, Dou, Q. Ping
Format: Artigo
Sprog:Inglês
Udgivet: 2017
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5722705/
https://ncbi.nlm.nih.gov/pubmed/29047025
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10555-017-9705-x
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!